Literature DB >> 1981913

Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.

B Poulain1, S Mochida, J D Wadsworth, U Weller, E Habermann, J O Dolly, L Tauc.   

Abstract

1. The effects on the release of transmitter by botulinum neurotoxins (BoNT; types A, B, E), tetanus toxin (TeTx), constituent chains or fragments were studied on identified cholinergic and non-cholinergic synapses in Aplysia. 2. Cholinergic synapses in the buccal ganglion were found to be greater than 100 fold more sensitive to extracellular application of BoNT than to TeTx whereas in non-cholinergic synapses of the cerebral ganglion the potencies of the toxins were reversed. When intracellularly applied TeTx and BoNT were found nearly equipotent. This disparity in the susceptibilities of BoNT and TeTx to inhibit transmission was attributed to differences in the toxin's acceptors or uptake systems in the two neurone types. 3. Micro-injection into cholinergic neurones of the isolated renatured toxins' chains showed that both light and heavy chains of BoNT are intracellularly required whereas the light chain of TeTx alone is sufficient. 4. The heavy chain of BoNT as well as that of TeTx were found to mediate internalization of active moieties via its amino-terminal half. Furthermore the heavy chain of one toxin could internalize the light chain of the other.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981913

Source DB:  PubMed          Journal:  J Physiol (Paris)        ISSN: 0021-7948


  8 in total

Review 1.  Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting.

Authors:  B R Singh
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 2.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

3.  Inhibition of transmitter release correlates with the proteolytic activity of tetanus toxin and botulinus toxin A in individual cultured synapses of Hirudo medicinalis.

Authors:  D Bruns; S Engers; C Yang; R Ossig; A Jeromin; R Jahn
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

4.  Toxic effects of tetanus toxin on GG2EE macrophages: prevention of gamma interferon-mediated upregulation of lysozyme-specific mRNA levels.

Authors:  L Pitzurra; E Blasi; M Puliti; F Bistoni
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence.

Authors:  S M Whelan; M J Elmore; N J Bodsworth; J K Brehm; T Atkinson; N P Minton
Journal:  Appl Environ Microbiol       Date:  1992-08       Impact factor: 4.792

6.  Dietary Plant Lectins Appear to Be Transported from the Gut to Gain Access to and Alter Dopaminergic Neurons of Caenorhabditis elegans, a Potential Etiology of Parkinson's Disease.

Authors:  Jolene Zheng; Mingming Wang; Wenqian Wei; Jeffrey N Keller; Binita Adhikari; Jason F King; Michael L King; Nan Peng; Roger A Laine
Journal:  Front Nutr       Date:  2016-03-07

7.  Botulinum Neurotoxin A Injected Ipsilaterally or Contralaterally into the Striatum in the Rat 6-OHDA Model of Unilateral Parkinson's Disease Differently Affects Behavior.

Authors:  Veronica A Antipova; Carsten Holzmann; Oliver Schmitt; Andreas Wree; Alexander Hawlitschka
Journal:  Front Behav Neurosci       Date:  2017-06-21       Impact factor: 3.558

8.  Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc.

Authors:  G Schiavo; B Poulain; O Rossetto; F Benfenati; L Tauc; C Montecucco
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.